愛朋醫療(300753.SZ):愛普投資及關繼峯合計減持28.51萬股 減持計劃已實施完成
格隆匯1月23日丨愛朋醫療(300753.SZ)公佈,公司於2020年1月23日收到愛普投資出具的《關於減持股份實施情況告知函》,截至2020年1月23日,愛普投資已減持公司股份3.91萬股,其餘87股在減持區間內不再減持,上述減持計劃已實施完成。
公司於2020年1月23日收到關繼峯出具的《關於減持股份實施情況告知函》,截至2020年1月23日,關繼峯已減持公司股份約24.6萬股,其餘42股在減持區間內不再減持,上述減持計劃已實施完成。
此次減持前,關繼峯直接持有公司股份94.09萬股,通過天峯啟航間接持有公司43,307股。截至公告披露日,關繼峯直接持有公司股份約7.39萬股,不再間接持有公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.